Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pharming Q2 EPS $(0.002) Down From $0.002 YoY, Sales $74.10M Up From $54.90M YoY

Author: Benzinga Newsdesk | August 01, 2024 01:42am

Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.00) per share. The company reported $74.10 million in sales this quarter. This is a 34.97 percent increase over sales of $54.90 million the same period last year.

Posted In: PHAR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist